The historical rank and industry rank for Central Pharmaceuticals's OCF Margin % or its related term are showing as below:
DHA:CENTRALPHL'
s OCF Margin % Range Over the Past 10 Years
Min: -15.45 Med: -0.27 Max: 8.93
Current: 0.02
During the past 13 years, the highest OCF Margin % of Central Pharmaceuticals was 8.93%. The lowest was -15.45%. And the median was -0.27%.
DHA:CENTRALPHL's OCF Margin % is ranked worse than 73.1% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs DHA:CENTRALPHL: 0.02
Central Pharmaceuticals OCF Margin % Related Terms
Central Pharmaceuticals OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:CENTRALPHL vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Central Pharmaceuticals OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Central Pharmaceuticals's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Central Pharmaceuticals (DHA:CENTRALPHL) has a OCF Margin % of 0.07% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Central Pharmaceuticals and its competitors. According to the industry distribution chart, Central Pharmaceuticals ranks #701 out of 959 companies in the Drug Manufacturers industry, placing it in the top 73.1%.
Is Central Pharmaceuticals' OCF Margin % too high?
Central Pharmaceuticals' current OCF Margin % is 0.07%. The Drug Manufacturers industry median OCF Margin % is 9.95. Central Pharmaceuticals' value of 0.07% is 99.3% below this industry median. Based on the distribution chart, Central Pharmaceuticals ranks #701 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Central Pharmaceuticals has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceuticals' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Central Pharmaceuticals ranks #701 out of 959 companies for OCF Margin %. This places Central Pharmaceuticals in the lower half of its industry. The industry median OCF Margin % is 9.95. Central Pharmaceuticals' value of 0.07% is 99.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Central Pharmaceuticals's current OCF Margin % of 0.07% is 99.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Central Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Central Pharmaceuticals's current OCF Margin % is 0.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Central Pharmaceuticals (DHA:CENTRALPHL) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT11.96, compared to a current price of BDT9.90 — trading 17.2% below its estimated fair value. The current OCF Margin % is 0.07% and 99.3% below the Drug Manufacturers industry median of 9.95. Central Pharmaceuticals' overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Central Pharmaceuticals (DHA:CENTRALPHL), the current OCF Margin % is 0.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Central Pharmaceuticals (DHA:CENTRALPHL) Overvalued in 2026?
Based on GuruFocus' analysis, Central Pharmaceuticals stock appears to be undervalued.
The current stock price of BDT9.90 is trading 17.2% below its estimated GF Value™ of BDT11.96.
GuruFocus considers Central Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for DHA:CENTRALPHL:
OCF Margin %: 0.07%
GF Value™: BDT11.96 vs. price of BDT9.90 (17.2% below fair value)
Industry Position: 99.3% below the Drug Manufacturers median (#701 of 959)
No single metric tells the full story. See the DHA:CENTRALPHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished pharmaceutical formulations, including tablets, capsules, liquids, ointments, and injectables, covering therapeutic areas such as anti-infectives, cardiovascular treatments, pain management, and gastrointestinal remedies. It conducts production and sales exclusively in the domestic market through its own facilities and distribution network. The company generates revenue from the sales of its pharmaceutical preparations.
61GF Score
Get the complete analysis for DHA:CENTRALPHL
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:CENTRALPHL has been successfully added to your 
